Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Recent Advances in Prostate Cancer and BPH

F.H. Schröder (Herausgeber)

Buch | Hardcover
302 Seiten
1996
Taylor & Francis Ltd (Verlag)
978-1-85070-784-4 (ISBN)
CHF 177,95 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
This volume focuses on the recent advances made in the diagnosis, prevention and management of prostate cancer. Among many important presentations, data on present and novel treatment modalities and early detection procedures are featured.
This is the most complete, authoritative reference work available on the newest developments in treating prostate cancer and benign hypertrophic hyperplasia. It contains more than 30 state-of-the-art contributions by world-class specialists covering every major topic in prostate cancer and BPH today. Several chapters deal with PSA for screening and prognosis and many present original new data from European studies not usually included in American texts.

Rationale for trials of screening for prostate cancer. Utility of total serum PSA, free total ratio, age specific reference ranges, and PSAD. BPH: characteristics of the disease observed in the general population. Trends in post-radical prostatectomy incontinence. The ratio of free to total prostate specific antigen level. Chemoprevention of prostate cancer and the Prostate Cancer Prevention Trial. PSA and the natural course of prostate cancer. Can progression of prostate cancer be predicted by pretreatment parameters? Watchful waiting as a treatment option in the management of clinical localized prostate cancer. Sexual function before and after radical prostatectomy. Intermittent androgen suppression. 5alpha-Reductase inhibition of the treatment of prostate cancer. European randomized study of screening for prostate cancer. Endocrine therapy. PSA and other serum markers as prognostic factors of response duration and patient survival in metastatic prostate carcinoma. Early vs. d elayed endocrine treatment. Combination therapy. Free and total PSA. Can we safely exclude patients with confined prostate cancer from treatment. Western diet and prostate cancer. Incontinence after radical prostatectomy. Preservation of continence after radical prostatectomy. Radical prostatectomy in the treatment of locally confined prostate cancer. Finasteride in BPH. Characteristics of prostate cancer. Molecular alterations associated with prostate cancer development. Post-radical prostatectomy incontinence. Antiandrogens as monotherapy. The European randomized study of screening for prostate cancer. New and old interventions in BPH. intermittent endocrine treatment. Rising prostate-specific antigen. Hot flushes under endocrine treatment. PSA response following radical radiation therapy. Index.

Erscheint lt. Verlag 15.11.1996
Verlagsort London
Sprache englisch
Gewicht 998 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Urologie
ISBN-10 1-85070-784-7 / 1850707847
ISBN-13 978-1-85070-784-4 / 9781850707844
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95